help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 27, 2007
Endocrinology, doi:10.1210/en.2007-0699
A more recent version of this article appeared on December 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/12/6186    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellacott, K. L.J.
Right arrow Articles by Cone, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellacott, K. L.J.
Right arrow Articles by Cone, R. D.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Nutrition
*Obesity

Submitted on May 23, 2007
Accepted on September 19, 2007

Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling

Kate L.J. Ellacott, Jonathan G. Murphy, Daniel L. Marks, and Roger D. Cone*

Center for the Study of Weight Regulation and Associated Disorders, Department of Pediatrics, Vollum Institute, Oregon Health and Science University, Portland, Oregon

* To whom correspondence should be addressed. E-mail: cone{at}ohsu.edu.

Metabolic syndrome, a complex of highly debilitating disorders that includes insulin resistance, hypertension, and dyslipidemia, is associated with the development of obesity in humans, as well as in rodent models. White adipose tissue (WAT) inflammation, caused in part by macrophage infiltration, and fat accumulation in the liver are both linked to development of the metabolic syndrome.

Despite large increases in body fat, melanocortin 3-receptor (MC3-R) deficient mice do not get fatty liver disease or severe insulin resistance. This is in contrast to obese melanocortin 4-receptor (MC4-R) deficient mice and diet-induced obese (DIO) mice which show increased adiposity, fatty liver disease and insulin resistance. We hypothesized that defects in the inflammatory response to obesity may underlie the protection from metabolic syndrome seen in MC3-R null mice. MC4-R mice fed a chow diet show increased pro-inflammatory gene expression and macrophage infiltration in WAT, as do WT DIO mice. In contrast MC3-R deficient mice fed a normal chow diet show neither of these inflammatory changes, despite their elevated adiposity, and a comparable degree of adipocyte hypertrophy to the MC4-R null and DIO mice.

Furthermore, even when challenged with high-fat chow for 4 weeks, a period of time shown to induce an inflammatory response in WAT of WT animals, MC3-R nulls showed an attenuated upregulation in both monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor alpha (TNF{alpha}) mRNA in WAT compared to WT high-fat fed animals.


Key words: Melanocortin • inflammation • macrophage • obesity • adipose







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society